手术满意度调查问卷 (ESSQ-19):俄语版本的语言调整和验证
F Rider1, A Turchinets1, M Zinchuk1
1Research and Clinical Center for Neuropsychiatry, Moscow, Russian Federation.
Epilepsy & behavior : E&B
|August 29, 2025
概括
俄罗斯手术满意度问卷 (Ru-ESSQ-19) 是衡量手术后患者幸福感的可靠工具. 这项验证为接受手术的俄语人士提供了以患者为中心的关键数据.
科学领域:
- 神经外科
- 患者报告的结果
- 心理测量
背景情况:
- 患者的满意度是手术的一个关键结果.
- 验证患者报告的结果措施对于临床实践至关重要.
- 手术满意度调查问卷 (ESSQ-19) 评估患者对手术的满意度.
研究的目的:
- 验证俄罗斯版本的手术满意度调查问卷 (Ru-ESSQ-19).
- 评估Ru-ESSQ-19在讲俄语的焦点抗药性患者中的可靠性和有效性.
主要方法:
- 翻译和反译ESSQ-19的俄语.
- 在手术后至少一年的患者接受Ru-ESSQ-19和其他验证的问卷.
- 统计分析包括Cronbach的内部一致性和Spearman的结构有效性等级相关性.
- 多重线性回归以确定满意度的预测因素.
主要成果:
- 在Ru-ESSQ-19中显示出高的内部一致性 (Cronbach的α=0.74-0.93).
- 问卷显示了与生活质量和相关的残疾措施的显著相关性.
- 鲁-ESSQ-19在预测发作自由度和感知障碍方面表现出良好的区分有效性.
- 与有关的残疾和服用抗药物的数量是满意度的重要预测指标.
结论:
- 在俄语人口中,Ru-ESSQ-19是评估手术后患者满意度的可靠和有效工具.
- 这种验证为评估俄罗斯手术队伍中以患者为中心的结果提供了有价值的工具.
- 这些发现提供了对俄罗斯术后患者满意度和影响因素的见解.
更多相关视频
05:48Author Spotlight: Investigating the Impact of Emotional Prosodies on Voice Recognition and Perception
Published on: August 9, 2024
1.6K
09:00Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
Published on: August 16, 2024
908
相关概念视频
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...